Corient Private Wealth’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$525K Buy
2025
Q2
$230K Buy
2025
Q1
Sell
2024
Q4
$347K Sell
2024
Q3
$432K Buy
2024
Q2
$443K Sell
2024
Q1
$604K Buy
2023
Q4
$551K Sell
2023
Q3
$424K Buy
2023
Q2
$429K Sell
2023
Q1
$356K Buy
2022
Q4
$292K Buy